Patients with psoriasis are at an increased risk for metabolic syndrome and often have greater risk factors for cardiovascular disease (CVD), according to study findings published in the Journal of the American Academy Dermatology.
The cross-sectional study included 260 consecutive patients with psoriasis and coronary computed tomography angiography results and data for metabolic syndrome classification (mean age, 50 years). Patients meeting 3 or more harmonized International Diabetes Federation criteria were considered to have metabolic syndrome. Approximately 31% (n=80) of patients with psoriasis met these criteria and were labeled as having metabolic syndrome.
Psoriasis Increases Risk for Metabolic Syndrome and Higher Coronary Plaque Burden
